Please wait...
About This Project
Therapeutics in any modality to combat Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infections are in urgent demand across the entire world as the Coronavirus Disease 2019 (COVID-19) pandemic continues to interrupt the well-being of human life. Without clinical therapeutics available for any of the human coronaviruses, a key starting point is to focus on target-based high-throughput screening (HTS) to reveal potent anti-SARS-CoV-2 hit-to-leads that are safe to human cells.
More Lab Notes From This Project
![Blast off!](https://d1sg0ksu7mr16v.cloudfront.net/admin_uploads/emails/April/EFF_rocket.gif)
Browse Other Projects on Experiment
Related Projects
Developing a low-cost, rapid diagnostic for urogenital Schistosomiasis infection
We are developing a frugal diagnostic for urogenital schistosomiasis, a neglected tropical disease that...
Can we biologically extend the range of human vision into the near infrared?
We have developed a protocol to augment human sight to see into the near infrared range through human formation...
NoAAC Longitudinal Registry of Treatment Outcomes in iSGS
Idiopathic subglottic stenosis (iSGS) is a rare and life-threatening disease involving airway obstruction...